Literature DB >> 12169210

Comparative study of some energetic and steric parameters of the wild type and mutants HIV-1 protease: a way to explain the viral resistance.

Speranta Avram1, L Movileanu, D Mihailescu, Maria-Luiza Flonta.   

Abstract

Because, in vivo, the HIV-1 PR ( HIV-1 protease) present a high mutation rate we performed a comparative study of the energetic behaviors of the wild type HIV-1 PR and four type of mutants: Val82/Asn; Val82/Asp; Gln7/Lys, Leu33/Ile, Leu63/Ile; Ala71/Thr, Val82/Ala. We suggest that the energetic fluctuation (electrostatic, van der Waals and torsion energy) of the mutants and the solvent accessible surface (SAS) values can be useful to explain the viral resistance process developed by HIV-1 PR. The number and localization of enzyme mutations induce important modifications of the van der Waals and torsional energy, while the electrostatic energy has an insignificant fluctuation. We showed that the viral resistance can be explored if the solvent accessible surfaces of the active site for the mutant structures are calculated. In this paper we have obtained the solvent accessible surface for a group of 15 mutants (11 mutants obtained by Protein Data Bank (PDB) file, 4 mutants modeled by CHARMM software) and for the wild type HIV-1 PR). Our study try to show that the number and localization of the mutations are factors which induce the HIV-1 PR viral resistance. The larger solvent accessible surface could be recorded for the point mutant Val 82/Phe.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12169210      PMCID: PMC6740297          DOI: 10.1111/j.1582-4934.2002.tb00192.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  3 in total

1.  Heterodimeric interaction and interfaces of S100A1 and S100P.

Authors:  Guozheng Wang; Shu Zhang; David G Fernig; David Spiller; Marisa Martin-Fernandez; Hongmei Zhang; Yi Ding; Zihe Rao; Philip S Rudland; Roger Barraclough
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

2.  Quantitative structure-activity relationship by CoMFA for cyclic urea and nonpeptide-cyclic cyanoguanidine derivatives on wild type and mutant HIV-1 protease.

Authors:  Speranta Avram; Cristian Bologa; Maria-Luiza Flonta
Journal:  J Mol Model       Date:  2005-02-16       Impact factor: 1.810

3.  Correlation between the predicted and the observed biological activity of the symmetric and nonsymmetric cyclic urea derivatives used as HIV-1 protease inhibitors. A 3D-QSAR-CoMFA method for new antiviral drug design.

Authors:  Speranta Avram; I Svab; C Bologa; Maria-Luiza Flonta
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.